Explore the latest news, real-world incidents, expert analysis, and trends in Citrix — only on The Hacker News, the leading ...

“Been thinking a lot about whether it’s possible to stop humanity from developing A.I.,” Altman wrote. “I think the answer is ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

AI developers are striving for self-improvement, aiming for technology that can enhance itself. Concerns about AI escaping ...

AI can help with those tasks. Recursive self-improvement takes that a step further: An AI helps build a successor that is ...

Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...

The Anthropic researcher quit, warning future AI could wipe out humanity, with senior colleagues publicly backing concerns.

Jeannie Kim is Executive Deputy Editor at Health. As an editor and writer, she has contributed to print and online publications including Good Housekeeping, Women's Health, and Match.com; she is also ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...